Glenmark Life Sciences Limited's market cap is currently ₹111.11B. The company's EPS TTM is ₹10.6; its P/E ratio is 22.39; and it has a dividend yield of 0.56%. Glenmark Life Sciences Limited is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 22
Dec 22
Dec 21
Dec 19
Currency in INR
Glenmark Life Sciences Limited Earnings and Revenue History
